Community Outreach and Engagement

项目摘要：社区外展和参与 Jackilen Shannon博士，M.P.H.社区外展和参与副主任 Knight癌症研究所（KCI）的社区外展和参与（COE）致力于识别和 通过参与解决我们的集水区俄勒冈州癌症负担的差异 与我们的社区和KCI的科学家。COE以社区的九项原则为我们的工作建模 参与由有毒物质和疾病登记署定义，并作为 临床和转化科学奖（CTSA）联盟的社区外展工作， 参与职能委员会。COE副总监，Jackilen Shannon博士，M.P.H. (CPC)，KCI 导演Brian Druker，医学博士(TO)由社区咨询委员会和KCI研究整合提供咨询 团队合作，为COE提供更广阔的视野。Tiffani霍华德博士，研究助理主任，监督- 通过社区伙伴关系倡议，与KCI的科学家进行接触和外联。医学博士阿曼达·布鲁格（CPC） 是临床助理主任，促进临床医生、临床研究和COE之间的沟通。 建立在KCI和社区之间长期的信任关系之上，COE活动 通过以下四个目标：1）定义和监测俄勒冈州的癌症负担和癌症需求， 持续的原始数据收集，现有数据资源的汇总，以及便利的社区输入; 2） 开展社区参与的外展活动，通过参与俄勒冈州的癌症需求 我们的集水区人口，以解决癌症预防，早期发现，治疗和生存的需要， 并提高所有人群的代表性，特别是那些受癌症影响的人群; 3） 促进与解决所有KCI集水区癌症优先事项相关的研究 4）增强社区方案和合作伙伴的能力，以有效地解决他们的问题。 通过社区赠款、培训和支持，解决社区最大的癌症相关问题。 与我们的社区合作，我们已经确定了优先癌症和行为，如乳腺癌， 肺癌/支气管癌、结肠直肠癌、前列腺癌、黑素瘤、胰腺癌和白血病/淋巴瘤，以及 戒烟和HPV疫苗接种。KCI的优先事项是通过仔细注意确定 种族/民族、地域和其他方面的差异，并注重增加代表性不足的人的参与 组COE向KCI领导层和科学家传达与癌症相关的需求和差异;实施 由我们的社区和KCI研究人员共同定义的COE计划;确定社区计划 活动，并共同实施癌症教育，筛查和预防计划;通知和协调KCI 我们的优先事项;并加强我们的能力，以满足社会对癌症研究的需求。

PROJECT SUMMARY: Community Outreach and Engagement Jackilen Shannon, Ph.D., M.P.H., Associate Director of Community Outreach and Engagement Community Outreach and Engagement (COE) at the Knight Cancer Institute (KCI) is dedicated to identifying and addressing disparities in cancer burden across our catchment area, the state of Oregon, through engagement with our communities and KCI scientists. COE models our work on the nine Principles of Community Engagement defined by the Agency for Toxic Substances and Disease Registry and developed as part of the work of the Clinical and Translational Science Awards (CTSA) Consortium's Community Outreach and Engagement Function Committee. COE Associate Director, Jackilen Shannon, Ph.D., M.P.H. (CPC), and KCI Director Brian Druker, M.D. (TO) are advised by a Community Advisory Board and the KCI Research Integration Team and provide the broader vision for COE. Tiffani Howard, Ph.D., Research Assistant Director, oversees in- reach to KCI scientists and outreach through the Community Partnership Initiative. Amanda Bruegl, M.D. (CPC) is Clinical Assistant Director and facilitates communication between clinicians, clinical research, and COE. Building on the long-standing and trusted relationships between KCI and the community, COE activities are informed by four objectives: 1) DEFINE and MONITOR the cancer burden and cancer needs in Oregon through ongoing primary data collection, aggregation of existing data resources, and facilitated community input; 2) CONDUCT community-engaged outreach activities responsive to cancer needs in Oregon by engaging with our catchment area population to address cancer prevention, early detection, treatment, and survivorship needs, and to enhance the representation of all populations, particularly those disproportionally impacted by cancer; 3) FACILITATE research relevant to addressing the cancer priorities of the catchment area across all KCI programs; and 4) AMPLIFY the capacity of community programs and partners to effectively address their communities' greatest cancer-related concerns through community grants, training, and support. In collaboration with our community, we have identified priority cancers and behaviors as breast, lung/bronchial, colorectal, prostate, melanoma, pancreatic cancer, and leukemia/lymphoma, as well as tobacco use cessation and HPV vaccination. KCI priorities are identified through careful attention to identifying racial/ethnic, geographic, and other disparities and focusing on increasing engagement of under-represented groups. COE communicates cancer-related needs and disparities to KCI leadership and scientists; implements COE initiatives that are defined jointly by our community and KCI researchers; identifies community program activities and jointly implements cancer education, screening, and prevention programs; informs and aligns KCI research with our priorities; and strengthens our capacity to address cancer research needs in the community.